Benchling, a biotech company out of Y Combinator providing cloud-based software for researchers, tells TechCrunch it has raised $7 million in growth funding to continue creating tools to help the science community access research from big pharma and other leaders in the space. You might think of Benchling as the Google Docs portion of the life sciences industry. While IT solutions software… Read More
Source: TechCrunch